# US 2022/0007987 A1 · Automated Neural Conduction Velocity Estimation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0007987 A1
- Document ID: US20220007987A1
- Status: Published application
- Kind: A1
- Application number: 17/287,501
- Filed: 2019-10-30
- Published: 2022-01-13
- Earliest claimed: 2018-10-30
- Assignees: Saluda Medical Pty Ltd
- Applicants: Saluda Medical Pty Ltd
- Inventors: Kai Huang; Matthew Marlon Williams
- Web page: https://patentgrep.com/patent/US20220007987A1

## CPC

- A61B 5/311: for nerve conduction study [NCS]
- A61B 5/4041: {Evaluating nerves condition}
- A61B 5/0031: {Implanted circuitry}
- A61B 5/294: for nerve conduction study [NCS]
- A61B 5/388: Nerve conduction study, e.g. detecting action potential of peripheral nerves
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/4848: {Monitoring or testing the effects of treatment, e.g. of medication}
- A61B 5/686: {Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence)}
- A61B 5/6877: {Nerve}
- A61B 5/7203: {for noise prevention, reduction or removal}
- A61N 1/0551: {Spinal or peripheral nerve electrodes}
- A61N 1/36071: {Pain}
- A61N 1/36139: {with automatic adjustment}
- A61B 5/4839: {combined with drug delivery}
- A61B 5/7282: {Event detection, e.g. detecting unique waveforms indicative of a medical condition (cough events A61B5/0823; seizures A61B5/4094; sleep apnoea A61B5/4818)}
- A61B 2560/0209: adapted for power saving
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

An implantable device, or an associated computer program, for estimating a nerve conduction velocity. A stimulus is applied from one or more stimulus electrodes to a nerve. A digitised neural measurement of at least one compound action potential evoked by the at least one stimulus is obtained from one or more recording electrodes by measurement circuitry. The digitised neural measurement comprises a plurality of data sample points. The digitised neural measurement is processed in order to estimate within subsample precision a temporal position of a feature of interest of the compound action potential. From the estimated temporal position of the feature of interest, and from a propagation distance, a conduction velocity of the compound action potential is determined.

## Claims

### Claim 1

An implantable device for estimating a nerve conduction velocity, the device comprising:
at least one stimulus electrode and at least one measurement electrode;
measurement circuitry for obtaining a neural measurement from the or each measurement electrode; and
a processor configured to apply from the or each stimulus electrode to a nerve at least one stimulus, obtain from the measurement circuitry a digitised neural measurement of at least one compound action potential evoked by the at least one stimulus, the digitised neural measurement comprising a plurality of data sample points, the processor further configured to process the digitised neural measurement in order to estimate within subsample precision a temporal position of a feature of interest of the compound action potential, and the processor further configured to determine from the estimated temporal position of the feature of interest and from a propagation distance a conduction velocity of the compound action potential.

### Claim 2 (depends on 1)

The implantable device of claim 1 wherein the processor is further configured to apply a plurality of stimuli and to obtain from the measurement circuitry a plurality of measurements each comprising a digitised neural measurement of the respective ECAP arising from each such stimuli.

### Claim 3 (depends on 2)

The implantable device of claim 2 wherein the processor is configured to obtain the plurality of measurements from a single measurement electrode, or from a single measurement electrode pair.

### Claim 4 (depends on 2)

The implantable device of claim 2 wherein the processor is configured to process the plurality of measurements in order to coarsely locate a selected ECAP feature temporally in each such measurement, and wherein the processor is further configured to process the coarsely located features from the plurality of measurements in order to produce an improved temporal location of the feature to within subsample precision.

### Claim 5 (depends on 4)

The implantable device of claim 4 wherein the processor is configured to process the coarsely located features from the plurality of measurements by finding the temporal mean of the coarsely located features in order to produce the improved temporal location of the feature to within subsample precision.

### Claim 6 (depends on 2)

The implantable device of claim 2, wherein the processor is configured to temporally separate the sample points of each measurement from the sample points of the other measurements relative to the respective ECAP, by changing a sampling start time by a sub-sample-period amount between obtaining each such measurement.

### Claim 7 (depends on 2)

The implantable device of claim 2 wherein the processor is further configured to obtain at least one digitised neural measurement of at least one compound action potential evoked by the at least one stimulus from a second measurement electrode, the second measurement electrode being at a different distance from the stimulus site.

### Claim 8 (depends on 2)

The implantable device of claim 2 wherein the processor is further configured to obtain neural response measurements at a first coarse sampling rate at some times, and to obtain neural response measurements at a second higher sampling rate at other times when it is desired to obtain a conduction velocity measurement.

### Claim 9 (depends on 1)

The implantable device of claim 1 wherein the feature of interest of the compound action potential comprises at least one of: a P1 peak, an N1 peak, a P2 peak, an ECAP onset, and an ECAP zero crossing.

### Claim 10 (depends on 1)

The implantable device of claim 1 wherein the processor is further configured to estimate from the conduction velocity of the neural response, or from changes in the conduction velocity of the neural response as detected from one measurement to a next measurement, a proportion of fibre classes recruited to produce the neural response.

### Claim 11 (depends on 10)

The implantable device of claim 10 wherein the processor is further configured to apply feedback control of an applied stimulus based on the estimated proportion of fibre classes recruited, in order to preferentially recruit selected fibre types to achieve beneficial therapeutic effects.

### Claim 12 (depends on 1)

The implantable device of claim 1 wherein the processor is further configured to apply feedback control of an applied stimulus based on the measure of conduction velocity.

### Claim 13

A method for estimating conduction velocity of a neural response, the method comprising:
obtaining digitized measurements of the neural response from at least two electrodes which are at distinct locations along a neural pathway, the digitised measurements comprising a plurality of data sample points;
processing the digitised neural measurement in order to estimate within subsample precision a temporal position of a feature of interest of the compound action potential;
determining from the estimated temporal position of the feature of interest a delay between the time of arrival of the neural response at each respective electrode; and
estimating from the delay, and from knowledge of electrode spacing, a conduction velocity of the neural response.

### Claim 14

A system for determining neural conduction velocity from clinical data of an implanted neuromodulation device, the system comprising:
an implanted neuromodulation device configured to deliver electrical neurostimulation therapy, and configured to capture digitised recordings of neural responses to the electrical neurostimulation therapy, and configured to communicate clinical data including digitised recordings of neural responses to a non-implanted receiver; and
a supervisory device configured to receive clinical data from the implanted neuromodulation device via the receiver, and to execute an automated procedure for determining conduction velocity from the digitised recordings.

### Claim 15 (depends on 14)

The system of claim 14, wherein the supervisory device is further configured to estimate within subsample precision a temporal position of a feature of interest of the compound action potential.

### Claim 16 (depends on 14)

The system of claim 14 wherein the implanted neuromodulation device is further configured to apply a plurality of stimuli and to obtain from the measurement circuitry a plurality of measurements each comprising a digitised neural measurement of the respective ECAP arising from each such stimuli.

### Claim 17 (depends on 16)

The system of claim 16 wherein the implanted neuromodulation device is configured to obtain the plurality of measurements from a single measurement electrode, or from a single measurement electrode pair.

### Claim 18 (depends on 16)

The system of claim 16 wherein the supervisory device is configured to process the plurality of measurements in order to coarsely locate a selected ECAP feature temporally in each such measurement, and wherein the supervisory device is further configured to process the coarsely located features from the plurality of measurements in order to produce an improved temporal location of the feature to within subsample precision.

### Claim 19 (depends on 18)

The system of claim 18 wherein the supervisory device is configured to process the coarsely located features from the plurality of measurements by finding the temporal mean of the coarsely located features in order to produce the improved temporal location of the feature to within subsample precision.

### Claim 20 (depends on 16)

The system of claim 16, wherein the supervisory device is configured to temporally separate the sample points of each measurement from the sample points of the other measurements relative to the respective ECAP, by changing a sampling start time by a sub-sample-period amount between obtaining each such measurement.

### Claim 21 (depends on 16)

The system of claim 16 wherein the implanted neuromodulation device is further configured to obtain at least one digitised neural measurement of at least one compound action potential evoked by the at least one stimulus from a second measurement electrode, the second measurement electrode being at a different distance from the stimulus site.

### Claim 22 (depends on 16)

The system of claim 16 wherein the implanted neuromodulation device is further configured to obtain neural response measurements at a first coarse sampling rate at some times, and to obtain neural response measurements at a second higher sampling rate at other times when it is desired to obtain a conduction velocity measurement.

### Claim 23 (depends on 14)

The system of claim 14 wherein the feature of interest of the compound action potential comprises at least one of: a P1 peak, an N1 peak, a P2 peak, an ECAP onset, and an ECAP zero crossing.

### Claim 24 (depends on 14)

The system of claim 14 wherein the supervisory device is further configured to estimate from the conduction velocity of the neural response, or from changes in the conduction velocity of the neural response as detected from one measurement to a next measurement, a proportion of fibre classes recruited to produce the neural response.

### Claim 25 (depends on 14)

The system of claim 14 wherein the implanted neuromodulation device is further configured to apply feedback control of an applied stimulus based on the measure of conduction velocity.

### Claim 26

A non-transitory computer readable medium for determining conduction velocity from clinical data of an implanted neuromodulation device, comprising instructions which, when executed by one or more processors, causes performance of the following:
receiving clinical data from the implanted neuromodulation device, the clinical data including digitised recordings captured by the implanted neuromodulation device of neural responses to electrical neurostimulation therapy delivered by the implanted neuromodulation device; and
executing an automated procedure for determining conduction velocity from the digitised recordings.
